[HTML][HTML] Self-assembling protein nanoparticles in the design of vaccines

J López-Sagaseta, E Malito, R Rappuoli… - Computational and …, 2016 - Elsevier
For over 100 years, vaccines have been one of the most effective medical interventions for
reducing infectious disease, and are estimated to save millions of lives globally each year …

Plasmodium genomics: an approach for learning about and ending human malaria

JA Garrido-Cardenas, L González-Cerón… - Parasitology …, 2019 - Springer
Malaria causes high levels of morbidity and mortality in human beings worldwide. According
to the World Health Organization (WHO), about half a million people die of this disease each …

Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …

S Rts - Lancet, 2015 - thelancet.com
Background The efficacy and safety of the RTS, S/AS01 candidate malaria vaccine during
18 months of follow-up have been published previously. Herein, we report the final results …

Novel protein-based pneumococcal vaccines: assessing the use of distinct protein fragments instead of full-length proteins as vaccine antigens

T Lagousi, P Basdeki, J Routsias, V Spoulou - Vaccines, 2019 - mdpi.com
Non-serotype-specific protein-based pneumococcal vaccines have received extensive
research focus due to the limitations of polysaccharide-based vaccines. Pneumococcal …

Structure Based Docking and Molecular Dynamic Studies of Plasmodial Cysteine Proteases against a South African Natural Compound and its Analogs

TM Musyoka, AM Kanzi, KA Lobb, Ö Tastan Bishop - Scientific reports, 2016 - nature.com
Identification of potential drug targets as well as development of novel antimalarial
chemotherapies with unique mode of actions due to drug resistance by Plasmodium …

Immune senescence and vaccines to prevent herpes zoster in older persons

MJ Levin - Current opinion in immunology, 2012 - Elsevier
Varicella-zoster virus (VZV) T-cell-mediated immunity (VZV-CMI) in older persons prevents
latent VZV in sensory neurons from reactivating to cause herpes zoster. VZV-CMI declines …

A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and …

V Ramasamy, U Arora, R Shukla… - PLoS neglected …, 2018 - journals.plos.org
Background Dengue is one of the fastest spreading vector-borne diseases, caused by four
antigenically distinct dengue viruses (DENVs). Antibodies against DENVs are responsible …

Optimized blanching reduces the host cell protein content and substantially enhances the recovery and stability of two plant-derived malaria vaccine candidates

S Menzel, T Holland, A Boes, H Spiegel… - Frontiers in plant …, 2016 - frontiersin.org
Plants provide an advantageous expression platform for biopharmaceutical proteins
because of their low pathogen burden and potential for inexpensive, large-scale production …

Development of new strategies for malaria chemoprophylaxis: from monoclonal antibodies to long-acting injectable drugs

JJ Moehrle - Tropical Medicine and Infectious Disease, 2022 - mdpi.com
Drug discovery for malaria has traditionally focused on orally available drugs that kill the
abundant, parasitic blood stage. Recently, there has also been an interest in injectable …

[HTML][HTML] Downstream processing of a plant-derived malaria transmission-blocking vaccine candidate

S Menzel, T Holland, A Boes, H Spiegel… - Protein Expression and …, 2018 - Elsevier
Plants as a platform for recombinant protein expression are now economically comparable
to well-established systems, such as microbes and mammalian cells, thanks to advantages …